Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
Hepatology2020Vol. 72(2), pp. 389–398
Citations Over TimeTop 10% of 2020 papers
Fang Lei, Ye‐Mao Liu, Feng Zhou, Juan‐Juan Qin, Peng Zhang, Lihua Zhu, Xiaojing Zhang, Jingjing Cai, Lijin Lin, Shan Ouyang, Xiaoming Wang, Chengzhang Yang, Xu Cheng, Weifang Liu, Haomiao Li, Jing Xie, Bin Wu, Huiming Luo, Fei Xiao, Jing Chen, Liang Tao, Gang Cheng, Zhi‐Gang She, Jianghua Zhou, Haitao Wang, Jun Lin, Pengcheng Luo, Shouzhi Fu, Jihui Zhou, Ping Ye, Bing Xiao, Weiming Mao, Li Liu, Youqin Yan, Ling Liu, Guohua Chen, Hongliang Li, Xiaodong Huang, Binghong Zhang, Yufeng Yuan
Abstract
The dynamic patterns of liver injury indicators and their potential risk factors may provide an important explanation for the COVID-19-associated liver injury. Because elevated liver injury indicators, particularly AST, are strongly associated with the mortality risk, our study indicates that these parameters should be monitored during hospitalization.
Related Papers
- → Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats(2016)36 cited
- → Liver enzyme abnormalities in taking traditional herbal medicine in Korea: A retrospective large sample cohort study of musculoskeletal disorder patients(2015)33 cited
- → Liver injury in COVID‐19: Diagnosis and associated factors(2020)12 cited
- → A Case Report of the Effect of Korean Medicine on Liver Function Test of Drug-Induced Liver Injury Patient Treated with Western Medicine(2014)4 cited
- → Isoniazid in Children – Any Rationale for Post Isoniazid Liver Function Test?(2022)